UBC PiMS Research Group (the Tremlett Laboratory)
Pharmacoepidemiology in Multiple Sclerosis Research Group (the Tremlett Laboratory)

New Discovery Grant Awarded by MS Society of Canada

Heterogeneity in the MS prodrome & impact on disease progression (PrOMS-HD). Clinical Research Project Grant Type: Discovery Grant (operating) by Multiple Sclerosis Society of Canada Total Funding – $99,983 (Canadian dollar) Funding Competitive?: Yes Funding Reference Number: (EGID): 903124 Multiple Funding Bodies

Top 3% of researchers cited globally (recognition).

Posted May/2022:  Ioannidis JPA, Baas J, Klavans R, Boyack KW (2019) A standardized citation metrics author database annotated for scientific field.

2023 Richardson Award and Lectureship

Awarded by the Canadian Neurological Society. The 2023 Richardson Lecture will be delivered at the Grand Plenary session, at the annual Congress, Banff, Canada. Honour presented by the Canadian Neurological Society

‘Women in the field of multiple sclerosis: How they contributed to paradigm shifts’

2023 Recognition: ‘Women in the field of multiple sclerosis: How they contributed to paradigm shifts’ Recognized for work related to the gut microbiome in pediatric-onset MS Source: Front. Mol. Neurosci., 03 February 2023. PMID: 36818652 (Canadian dollar)

ACTRIMS Forum 2023

The ACTRIMS Forum 2023, San Diego, California, Conference Date: 2023/2 Risk of Multiple Sclerosis in People with HIV: An International Cohort study. Authors: E. Kingwell, A. Manouchehrinia, F. Zhu, K. McKay, J. Li, M. Ye, P. Sereda, J. Trigg, K. Kooij, M. Gisslén, A. Ekström, J. Hillert, R. Hogg, H. Tremlett. Presentation Type: Oral Presentation […]

a place of mind, The University of British Columbia

Pharmacoepidemiology in MS (PiMS)
2211 Wesbrook Mall,
Vancouver, BC, V6T 2B5, Canada
Email:

Emergency Procedures | Accessibility | Contact UBC  | © Copyright The University of British Columbia